April 26, 2022
Join Trinity Life Sciences for a webinar that explores the findings from our TGaS report entitled, ‘Commercial and Medical Affairs Leaders Landscape 2022’. The study is based on the responses of 35 Commercial leaders and 24 Medical Affairs leaders representing 56 separate biopharmaceutical companies.
Commercial and Medical Affairs teams continue to play an important role in healthcare innovation and the value of having cross-functional collaboration is more critical than ever.
Join us for a dynamic discussion as we cover the…
April 7, 2022
Life science companies are often faced with situations that require quick decisions—from triage and/or pre-diligence phases through full due diligence. Trinity’s expert team routinely provides time-sensitive business development support, delivering robust insights and evidence-based answers in days. Come join us for a dynamic discussion on evaluating Business Development opportunities in life sciences.
Key Webinar Topics
What are the best approaches, data and tools to meet your business needs within your time horizon?How can you leverage rapid access to Real-World Evidence…
March 15, 2022
Companies frequently contract with various government channels as part of their contracting strategies. Each channel requires statutory price reporting, which drives manufacturer rebate calculations and/or provider reimbursement. With significant penalties for non-compliance and real financial impact on the bottom line, there is no room for error with government pricing calculations. Dynamic regulations add to the complexity.
Join TGaS’ pricing and contracting experts for an exclusive webinar for pre-commercial and emerging life science companies. We will discuss common challenges that companies…
March 15, 2022
This session will discuss trends in the HTA/Reimbursement environment in Latin America and the drivers for value-based health care (VBHC) implementation within the region. The potential benefits of VBHC, stakeholders’ roles in VBHC, contextual barriers and facilitators for VBHC implementation, and potential future impact of VBHC to healthcare in the region will be discussed by a panel of speakers.
Note: The webinar will be presented in Spanish and Portuguese with PowerPoint Slides shown in English.Dr. Hector Castro will moderate the session and…
March 10, 2022
Life science Competitive Intelligence (CI) is growing in importance and impact. From innovation in technology to the number of products launching to the more connected global marketplace, CI teams are wrestling with the needs of an evolving function. With more data coming at CI teams faster, organizations need to adapt and optimize or be left behind. Pulling from the initial findings of a recent study, Trinity’s team of CI-focused experts share insights and commentary on the opportunities and challenges facing…
March 2, 2022
Life science forecasters support complex analytical needs, all while grappling with ever-changing assumptions and datastreams. Working in Excel is often one of the few constants, but the comfort of working with a familiar tool frequently becomes a trade-off in functionality as forecasters pursue easy consolidation and communication, greater version control and intuitive scenario planning.
Trinity’s forecasting team has focused on life sciences forecasting and modeling projects for 25 years—and that breadth and depth of experience drove the creation of Trinity…
March 7, 2022
March 7 – March 10, 2022
Gene Therapy for Rare Disorders is dedicated to overcoming the unique drug development challenges encountered in transforming gene therapy concepts into reality for rare disease patients in need.
On Wednesday, March 9, join Krista Perry, Partner – Head of Launch Excellence and Blair Miller, Principal for the Trinity Life Sciences session on Best Practices for Optimizing Commercialization of Gene Therapies. Although commercially available gene therapies is still relatively limited, there are dozens on the…
November 16, 2021
In 2022, a key challenge for life sciences companies will be to identify the best ways to extract value from RWD to assess brand health for their unique context. Whether your brand is on-market already or is preparing for launch, leveraging a nuanced, evidence-based view of performance drivers – from prescriber adoption, to payer acceptance, to patient persistence – is essential to making the best decisions. Come join RWE experts from Trinity and Forian as they lead a lively discussion…
October 18, 2021
The TGaS Summit will bring together life science professionals to hear the latest market trends, network, and share best practices. The Summit will feature 14 different categories of Commercial Client Solutions focused on key issues, challenges, and opportunities identified by Commercial Leaders.
For more information on the TGaS Client Summits, please fill out the following and someone will contact you.…
September 29, 2021
According to a TGaS Advisors’ large landscape study, 45% of all machine learning commercial use cases in the life sciences industry were for finding patients, often for HCP alerts and targeting. In fact, if you are not doing patient finding alerts/targeting, you are probably behind the industry.
Come join TGaS Advisors, a division of Trinity Life Sciences, as we share the “ins and outs” of patient finding, including learnings from our study. It’s clear that patient finding can have a…